Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

-Karen Kelly Researcher Activity Profile

Research Author Detailed Information 

Are you KAREN KELLY?? Join now for FREE! You can update this page and your profile image by registering at Molecular Stationkaren kelly

Karen Kelly Publication Rate By Year

Karen Kelly has published 1 paper(s) in 2006, 3 paper(s) in 2007, 2 paper(s) in 2008, for a total of 6 research publications in total.

karen kelly researcher

Karen K Kelly Author Information

LAST NAME: kelly

FIRST NAME: karen

INITIALS: K

AFFILIATION:

Papers

Karen Kelly's Publication Record

  1. Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914. Year Published: 2007
  2. Caritas St. Elizabeth's Medical Center of Boston, Boston, MA 02135, USA. phesketh@massmed.org
  3. Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718. Year Published: 2007
  4. Caritas St. Elizabeth's Medical Center of Boston, Boston, Massachusetts 02135, USA. phesketh@massmed.org
  5. Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group Study (S9504). Year Published: 2006
  6. University of California, Davis Cancer Center, Sacramento, CA 95817, USA. david.gandara@ucdmc.ucdavis.edu
  7. EGFR-mutant lung adenocarcinoma in a patient with Li-Fraumeni syndrome. Year Published: 2007
  8. Department of Medicine, University of Colorado at Denver and Health Sciences Center, Aurora, CO, USA.
  9. Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: results from Southwest Oncology Group randomized trials. Year Published: 2008
  10. University of California Davis Cancer Center, 4501 X St, Sacramento, CA 95817, USA. primo.lara@ucdmc.ucdavis.edu
  11. Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: results from Southwest Oncology Group randomized trials. Year Published: 2008
  12. University of California Davis Cancer Center, 4501 X St, Sacramento, CA 95817, USA. primo.lara@ucdmc.ucdavis.edu
 

Molecular Station USER Menu

Welcome to Molecular Station!

You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

Already registered? Login now below.

User Name:

Password:

Already registered and Forgot your password? Click below to recover it.

Recover Lost Password

Join now - it's fast and free!

Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

Research Terms of Usage and Disclaimer
Home
Features

Protocols

DNA Forum

Science Forum

DNA Forum
Biology Forum

Science News


[CaRP] XML error: Invalid document end at line 2

For more click here:Science News